NCT03046784

Brief Summary

This prospective and observational trial over 55 pregnant women (third trimester) compares non invasive haemodynamic monitoring using Nexfin technology and ultrasonography technic

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
55

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2017

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2017

Completed
26 days until next milestone

First Submitted

Initial submission to the registry

January 27, 2017

Completed
12 days until next milestone

First Posted

Study publicly available on registry

February 8, 2017

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2017

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2017

Completed
Last Updated

April 22, 2020

Status Verified

April 1, 2020

Enrollment Period

3 months

First QC Date

January 27, 2017

Last Update Submit

April 21, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Cardiac output measure

    Cardiac output is measured with non-invasive digital Nexfin technology (ml/min) and compared with transthoracic echocardiographic measure of cardiac output (ml/min) used as reference. Echographic cardiac output (ml/min) is measured as the produce of cross sectional aera of left ventricular outflow track (cm²) multiplied by velocity time index (cm) multiplied by heart rate (beat/min)

    30 minutes

Study Arms (1)

Pregnant women in third trimester

Non-labouring pregnant women hospitalised during their third trimester of pregnancy has an haemodynamic evaluation with Nexfin technology and transthoracic cardiac ultrasonography. Evaluation is performed in two positions : dorsal decubitus and left lateral decubitus.

Other: haemodynamic evaluation

Interventions

continous haemodynamic monitoring is performed with digital Nexfin captor in two positions. in the same time transthoracic cardiac ultrasonography is performed to calculate cardiac output using velocity time index of aortic outflow chamber.

Pregnant women in third trimester

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility Detailspregmant women
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Non-labouring term pregmant women in their third trimester

You may qualify if:

  • third trimester of pregnancy
  • Non-labouring pregnant women
  • accepting study

You may not qualify if:

  • refusal of study
  • first or second trimester of pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Departement anesthesie reanimation hopital nord

Marseille, 13015, France

Location

Related Publications (2)

  • Montenij LJ, Buhre WF, Jansen JR, Kruitwagen CL, de Waal EE. Methodology of method comparison studies evaluating the validity of cardiac output monitors: a stepwise approach and checklist. Br J Anaesth. 2016 Jun;116(6):750-8. doi: 10.1093/bja/aew094.

    PMID: 27199309BACKGROUND
  • Lee SW, Khaw KS, Ngan Kee WD, Leung TY, Critchley LA. Haemodynamic effects from aortocaval compression at different angles of lateral tilt in non-labouring term pregnant women. Br J Anaesth. 2012 Dec;109(6):950-6. doi: 10.1093/bja/aes349. Epub 2012 Oct 11.

    PMID: 23059960BACKGROUND

MeSH Terms

Conditions

Cardiac Output, High

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Study Director, Clinical Professor

Study Record Dates

First Submitted

January 27, 2017

First Posted

February 8, 2017

Study Start

January 1, 2017

Primary Completion

March 31, 2017

Study Completion

May 31, 2017

Last Updated

April 22, 2020

Record last verified: 2020-04

Data Sharing

IPD Sharing
Will not share

Locations